IRhythm Technologies Net Worth

IRhythm Technologies Net Worth Breakdown

  IRTC
The net worth of iRhythm Technologies is the difference between its total assets and liabilities. IRhythm Technologies' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of IRhythm Technologies' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. IRhythm Technologies' net worth can be used as a measure of its financial health and stability which can help investors to decide if IRhythm Technologies is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in iRhythm Technologies stock.

IRhythm Technologies Net Worth Analysis

IRhythm Technologies' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including IRhythm Technologies' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of IRhythm Technologies' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform IRhythm Technologies' net worth analysis. One common approach is to calculate IRhythm Technologies' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares IRhythm Technologies' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing IRhythm Technologies' net worth. This approach calculates the present value of IRhythm Technologies' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of IRhythm Technologies' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate IRhythm Technologies' net worth. This involves comparing IRhythm Technologies' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into IRhythm Technologies' net worth relative to its peers.

Enterprise Value

1.65 Billion

To determine if IRhythm Technologies is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding IRhythm Technologies' net worth research are outlined below:
iRhythm Technologies appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 591.84 M. Net Loss for the year was (113.29 M) with profit before overhead, payroll, taxes, and interest of 429.23 M.
iRhythm Technologies has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company shares are owned by institutional investors
Latest headline from insidermonkey.com: Needham Downgrades CONMED Corporation to Hold from Buy

IRhythm Technologies Quarterly Good Will

862,000

IRhythm Technologies uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in iRhythm Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to IRhythm Technologies' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
22nd of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Know IRhythm Technologies' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as IRhythm Technologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading iRhythm Technologies backward and forwards among themselves. IRhythm Technologies' institutional investor refers to the entity that pools money to purchase IRhythm Technologies' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2025-03-31
750.4 K
Eventide Asset Management, Llc2025-03-31
740.1 K
Westfield Capital Management Company, L.p.2025-03-31
617.1 K
Bessemer Group Inc2025-03-31
574.1 K
Jpmorgan Chase & Co2025-03-31
562.5 K
Braidwell Lp2025-03-31
556.4 K
Stephens Inv Mgmt Group Llc2025-03-31
520.6 K
Allspring Global Investments Holdings, Llc2025-03-31
518.6 K
Fuller & Thaler Asset Management Inc2025-03-31
518.2 K
Vanguard Group Inc2025-03-31
3.1 M
Sands Capital Management, Llc2025-03-31
M
Note, although IRhythm Technologies' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow IRhythm Technologies' market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.35 B.

Market Cap

1.63 Billion

Project IRhythm Technologies' profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.12)(0.13)
Return On Capital Employed(0.14)(0.15)
Return On Assets(0.12)(0.13)
Return On Equity(1.25)(1.18)
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.19) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.19.
When accessing IRhythm Technologies' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures IRhythm Technologies' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of IRhythm Technologies' profitability and make more informed investment decisions.
Please note, the presentation of IRhythm Technologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IRhythm Technologies' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of IRhythm Technologies' management manipulating its earnings.

Evaluate IRhythm Technologies' management efficiency

iRhythm Technologies has return on total asset (ROA) of (0.0437) % which means that it has lost $0.0437 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1113) %, meaning that it created substantial loss on money invested by shareholders. IRhythm Technologies' management efficiency ratios could be used to measure how well IRhythm Technologies manages its routine affairs as well as how well it operates its assets and liabilities. As of July 20, 2025, Return On Tangible Assets is expected to decline to -0.13. In addition to that, Return On Capital Employed is expected to decline to -0.15. At present, IRhythm Technologies' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 52.7 M, whereas Other Current Assets are forecasted to decline to about 10.8 M.
Last ReportedProjected for Next Year
Book Value Per Share 2.91  3.98 
Tangible Book Value Per Share 2.89  3.90 
Enterprise Value Over EBITDA(42.23)(44.34)
Price Book Value Ratio 30.94  32.49 
Enterprise Value Multiple(42.23)(44.34)
Price Fair Value 30.94  32.49 
Enterprise Value2.6 B1.6 B
Understanding the operational decisions made by IRhythm Technologies management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue
7.3788
Revenue
618.6 M
Quarterly Revenue Growth
0.203
Revenue Per Share
19.741
Return On Equity
(1.11)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IRhythm Technologies insiders, such as employees or executives, is commonly permitted as long as it does not rely on IRhythm Technologies' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IRhythm Technologies insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Turakhia Minang over two weeks ago
Disposition of 1420 shares by Turakhia Minang of IRhythm Technologies at 145.41 subject to Rule 16b-3
 
Freeman Sean Clinton over two weeks ago
Insider Trading
 
Marc Rosenbaum over a month ago
Disposition of 696 shares by Marc Rosenbaum of IRhythm Technologies at 140.21 subject to Rule 16b-3
 
Turakhia Minang over a month ago
Acquisition by Turakhia Minang of 318 shares of IRhythm Technologies at 74.72 subject to Rule 16b-3
 
Snyderman Ralph over a month ago
Acquisition by Snyderman Ralph of 1358 shares of IRhythm Technologies subject to Rule 16b-3
 
Rubash Mark J over a month ago
Acquisition by Rubash Mark J of 1358 shares of IRhythm Technologies subject to Rule 16b-3
 
Chad Patterson over three months ago
Acquisition by Chad Patterson of 10742 shares of IRhythm Technologies subject to Rule 16b-3
 
Chad Patterson over six months ago
Acquisition by Chad Patterson of 10674 shares of IRhythm Technologies subject to Rule 16b-3
 
Murphy Patrick Michael over six months ago
Disposition of 2492 shares by Murphy Patrick Michael of IRhythm Technologies at 85.89 subject to Rule 16b-3
 
Daniel Wilson over six months ago
Disposition of 2452 shares by Daniel Wilson of IRhythm Technologies at 111.14 subject to Rule 16b-3
 
Mark Day over six months ago
Disposition of 1475 shares by Mark Day of IRhythm Technologies at 121.96 subject to Rule 16b-3
 
Bobzien Brice over six months ago
Disposition of 1372 shares by Bobzien Brice of IRhythm Technologies at 70.34 subject to Rule 16b-3

IRhythm Technologies Corporate Filings

F3
8th of July 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
8K
7th of July 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
2nd of July 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
27th of June 2025
Other Reports
ViewVerify
IRhythm Technologies time-series forecasting models is one of many IRhythm Technologies' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IRhythm Technologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

IRhythm Technologies Earnings per Share Projection vs Actual

IRhythm Technologies Corporate Management

Chad PattersonChief OfficerProfile
Brice CPAChief OfficerProfile
Mazi KianiVP RegulatoryProfile
Daniel WilsonExecutive RelationsProfile
Mintu MDChief OfficerProfile
MS MDChief InnovationProfile
When determining whether iRhythm Technologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IRhythm Technologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Irhythm Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Irhythm Technologies Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iRhythm Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade IRhythm Stock refer to our How to Trade IRhythm Stock guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IRhythm Technologies. If investors know IRhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IRhythm Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.13)
Revenue Per Share
19.741
Quarterly Revenue Growth
0.203
Return On Assets
(0.04)
Return On Equity
(1.11)
The market value of iRhythm Technologies is measured differently than its book value, which is the value of IRhythm that is recorded on the company's balance sheet. Investors also form their own opinion of IRhythm Technologies' value that differs from its market value or its book value, called intrinsic value, which is IRhythm Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IRhythm Technologies' market value can be influenced by many factors that don't directly affect IRhythm Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IRhythm Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if IRhythm Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IRhythm Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.